Geneos Wealth Management Inc. Anavex Life Sciences Corp. Call Options Transaction History
Geneos Wealth Management Inc.
- $3.77 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AVXL
# of Institutions
198Shares Held
32MCall Options Held
1.16MPut Options Held
804K-
Black Rock Inc. New York, NY6.39MShares$51.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$41 Million0.0% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$16.2 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY973KShares$7.82 Million0.02% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $626M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...